JAK3

JAK3, or Janus Kinase 3, is a vital member of the JAK kinase family, primarily active in immune system cells. JAK3, a non-receptor tyrosine kinase, is involved in the JAK-STAT signaling pathway, which is key to cytokine-mediated regulation of cell proliferation, differentiation, and apoptosis. The receptor's activity is essential for immune balance, and its irregular expression or malfunction is linked to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. JAK3 is also considered a potential target for cancer therapy. Inhibitors of JAK3, like tofacitinib, have been approved for treating certain autoimmune diseases, demonstrating efficacy and safety.